[Federal Register: April 26, 2004 (Volume 69, Number 80)]
[Notices]
[Page 22566]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26ap04-114]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importation of Controlled Substances; Notice of Application
Pursuant to section 1008 of the Controlled Substances Import and
Export Act (21 U.S.C. 958(1)), the Attorney General shall, prior to
issuing a registration under this section to a bulk manufacturer of a
controlled substance in Schedule I or II and prior to issuing a
regulation under section 1002(a) authorizing the importation of such a
substance, provide manufacturers holding registrations for the bulk
manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with Sec. 1301.34 of title 21, Code of
Federal Regulations (CFR), notice is hereby given that on February 18,
2004, Penick Corporation, 158 Mount Olivet Avenue, Neward, New Jersey
07114, made application by renewal to the Drug Enforcement
Administration to be registered as an importer of the basic classes of
controlled substances listed in Schedule II.
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Coca Leaves (9040)......................... II
Raw Opium (9600)........................... II
Poppy Straw (9650)......................... II
Concentrate Of Poppy Straw (9670).......... II
------------------------------------------------------------------------
The firm plans to import controlled substances to manufacture bulk
pharmaceutical controlled substances and non-controlled substance
flavor extract.
An manufacturer holding, or applying for, registration as a bulk
manufacturer of this basic class of controlled substances may file
written comments on or objections to the application described above
and may, at the same time, file a written request for a hearing on such
application in accordance with 21 CFR 1301.43 in such form as
prescribed by 21 CFR 1316.47.
Any such comments, objections, or requests for a hearing may be
addressed, in quintuplicate, to the Deputy Assistant Administrator,
Office of Diversion Control, Drug Enforcement Administration, United
States Department of Justice, Washington, DC 20537, Attention: Federal
Register Representative, Office of Chief Counsel (CCD) and must be
filed not later than (30 days from publication).
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1301.34(b), (c), (d),
(e), and (f). As noted in a previous notice at 40 FR 43745-46
(September 23, 1975), all applicants for registration to import basic
class of any controlled substance in Schedule I or II are and will
continue to be required to demonstrate to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration that the requirements for such registration pursuant to
21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1311.42(a), (b), (c),
(d), (e), and (f) are satisfied.
Dated: April 9, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 04-9327 Filed 4-23-04; 8:45 am]
BILLING CODE 4410-09-M